About Index Trending news
Analyze
Top 50 Pricing
Repligen

Repligen

Work at Repligen? Add yourself to this profile

Repligen

Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital
$4,000,000
Employees

Team size

50+
The Motley Fool

Read This Before You Sell Repligen Corporation Stock

The Motley Fool

Repligen Corporation Jumped 14.6% in February -- Here's Why

The Motley Fool

Why Repligen Corporation Shares Are Falling --